ArticleJournal of cardiothoracic surgery2026
Complete resection of solitary pulmonary metastases in thyroid cancer: a case series report.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAlthough the lung is the most common site of thyroid cancer metastasis, limited evidence of pulmonary metastasectomy is available. This study aimed to review the clinical course and outcomes of patients who underwent complete resection of solitary pulmonary metastases appearing during a watchful-waiting period.
methodsWe retrospectively reviewed 11 patients with pulmonary metastases from thyroid cancer who underwent pulmonary metastasectomies between January 2000 and December 2023 at Osaka International Cancer Institute.
resultsThe median patient age was 73 years. Eight patients had differentiated thyroid carcinoma (DTC), and three had non-DTC. All patients had previously undergone complete resection of their primary disease. The solitary pulmonary nodules were detected during the watchful-waiting period, with six preoperatively diagnosed as primary lung cancer and five as pulmonary metastases. All patients underwent complete resection of the pulmonary nodules, with intraoperative diagnoses confirmed in 10 cases. Among the patients with DTC, four patients experienced relapse-free survival for at least 66 months without the need for additional systemic therapy after pulmonary metastasectomy. The remaining three patients also survived without recurrence during the postoperative watchful-waiting period. In contrast, among the three patients with non-DTC, only one patient underwent repeated PM and achieved 47 months of disease control, while the other two patients experienced earlier recurrence.
conclusionsAlthough our data were limited to definitively conclude the efficacy of completely resecting solitary metastases, surgical resection could be recommended for a definitive diagnosis and potentially extending relapse-free survival in patients with DTC. However, given the poor and heterogeneous outcomes in non-DTC, the indication for PM should be carefully considered on a case-by-case basis. (263/350 words).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.